| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,880,000 | 2,456,000 | 2,086,000 | 2,491,000 | | Cost of Revenue | 1,399,000 | 1,333,000 | 1,280,000 | 1,394,000 | | | Gross Profit | 1,481,000 | 1,123,000 | 806,000 | 1,097,000 | | | Operating Expenses | | Research Development | 367,000 | 369,000 | 386,000 | 431,000 | | Selling General and Administrative | 341,000 | 326,000 | 305,000 | 362,000 | | Non Recurring | 10,000 | 85,000 | 105,000 | 254,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 763,000 | 343,000 | 10,000 | 50,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 14,000 | 5,000 | (14,000) | | Earnings Before Interest And Taxes | 764,000 | 357,000 | 15,000 | 36,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 764,000 | 357,000 | 15,000 | 36,000 | | Income Tax Expense | 226,000 | 97,000 | (2,000) | (71,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 538,000 | 260,000 | 17,000 | 107,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 538,000 | 260,000 | 17,000 | 107,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $538,000 | $260,000 | $17,000 | $107,000 |
|
0.51% Nasdaq 
Income Statement
